Katrine Fladeland Iversen

Author

Odense University Hospital ORCID

Also Known As

Iversen, K. F.; id_orcid 0000-0003-4494-9034, K IVERSEN, Katrine F. Iversen, Katrine Fladeland Iversen

Publications

222

Citations

H-Index

Concepts

All Affiliations

Odense University Hospital Vejle Sygehus University of Southern Denmark Rigshospitalet Aalborg University Hospital

About

Katrine Fladeland Iversen is an author at Odense University Hospital specializing in hematology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	137
2	Immunology	3	3	122
3	Pathology	3	3	122
4	Cell Biology	1	1	18
5	Nephrology	1	1	15

Katrine Fladeland Iversen

Publications

177

Citations

H-Index

Page 1

	Year	Citations
Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha Thomas Stauffer Larsen, Katrine Fladeland Iversen, Esben Hansen, Leukemia Research InflammationThrombosisPolycythemia VeraThrombopoiesisHematological Malignancy	2013	90
The real-world outcomes of multiple myeloma patients treated with daratumumab Agoston Gyula Szabo, Tobias Wirenfeldt Klausen, Mette Bøegh Levring, PLoS ONE	2021	23
Daratumumab for treatment of blastic plasmacytoid dendritic cell neoplasm. A single-case report Katrine Fladeland Iversen, Paw Christian Holdgaard, Birgitte Preiss, Haematologica Rare MalignancyImmunologyPathologySingle-case ReportImmunotherapy	2019	18
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study Agoston Gyula Szabo, Katrine Fladeland Iversen, Sören Möller, Clinical Hematology International	2019	17
Clinically‐suspected cast nephropathy: A retrospective, national, real‐world study Agoston Gyula Szabo, Jonathan Thorsen, Katrine Fladeland Iversen, American Journal of Hematology Glomerular DiseaseRenal PathologyRenal InflammationGlomerulonephritisRenal Function	2020	15
Extracellular Vesicles Isolated from Plasma of Multiple Myeloma Patients Treated with Daratumumab Express CD38, PD-L1, and the Complement Inhibitory Proteins CD55 and CD59 Kieran Brennan, Katrine Fladeland Iversen, Alfonso Blanco-Fernández, Cells Hematological MalignancyExtracellular VesiclesAutoimmune DiseaseMalignant Blood DisorderImmunology	2022	14

Page 1